Disclosure Panels Details Page

Melanoma Panel - Disclosures as of 09/02/2011

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty for Panel Member or Dependent Spouse/Domestic Partner/Dependent Potential Conflict Has Attended
Robert Andtbacka MD None Amgen Inc.
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
None None NA -
Christopher Anker MD None None None None NA
Christopher Bichakjian MD None None None None NA
William Carson III MD None None Castle Bioscience
Dragonfly Therapeutics
None NA
Daniel Coit MD, FACS None None None None NA
Adil Daud MD Abbott Laboratories
GlaxoSmithKline
Merck & Co., Inc.
Pfizer Inc.
Roche Laboratories, Inc.
Schering-Plough Corporation
Wyeth Pharmaceuticals
Amgen Inc.
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Oncosec
Serono
None Oncosec NA
Dominick DiMaio MD None None None None NA -
Lauren Gallagher None None None None None
Kristina Gregory MSN, RN, OCN None None None None NA -
Valerie Guild MBA None None None None NA
Allan Halpern MD Janssen Research & Development, LLC
Quintiles
Caliber ID
Canfield Scientific
DermTech
Emerald Medical Applications
Novartis Pharmaceuticals Corporation
SciBase
None None None -
Maria Ho None None None None NA
F. Stephen Hodi MD Bristol-Myers Squibb Company
Genentech, Inc.
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Pfizer Inc.
Amgen Inc.
Bristol-Myers Squibb Company
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Amgen Inc.
Bristol-Myers Squibb Company
Genentech, Inc.
GlaxoSmithKline
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Bristol-Myers Squibb Company None -
Mark Kelley MD, MMHC, FACS GlaxoSmithKline None None None NA
Nikhil Khushalani MD AstraZeneca Pharmaceuticals LP
Bristol-Myers Squibb Company
Celgene Corporation
CytRx
Eisai Inc.
Genentech, Inc.
Merck & Co., Inc.
NCCN (Grant funded clinical trials from the ORP)
Pfizer Inc.
Threshold
Tracon
Amgen Inc.
Bristol-Myers Squibb Company
Prometheus None NA
Ragini Kudchadkar Bristol-Myers Squibb Company
Genentech, Inc.
GlaxoSmithKline
Genentech, Inc. None None NA
Julie Lange MD, ScM None None None None NA -
Anne Lind MD None None None None NA
Mary Martini MD None dove- unilever None None None
Joan McClure MS None None None None NA
Nicole McMillian MS None None None None NA
Anthony Olszanski MD, RPh None Bristol-Myers Squibb Company
Merck & Co., Inc.
sanofi-aventis U.S.
None None NA -
Scott Pruitt MD, PhD None None None None NA -
Merrick Ross MD Amgen Inc. Amgen Inc.
Merck & Co., Inc.
Amgen Inc. None NA
Susan Swetter MD None None None None NA
Kenneth Tanabe MD NIH/DCP
Phase I clinical trial of oncolytic virus
Advance Medical
American Cancer Society
Best Doctors
Cancer Experts Now
Helix12
Leidos
UpToDate
None None NA -
John Thompson MD Calithera Pharmaceuticals AVEO Pharmaceuticals, Inc.
Iovance pharmaceuticals
Regeneron Pharmaceuticals, Inc.
None None NA
Vijay Trisal MD None None None None None -
Marshall Urist MD None None None None NA